Various Factors Influencing the Enantiomers of Warfarin Pharmacokinetics: A Systematic Review of Population Pharmacokinetics
Sirajudeen Mahaboob1,3, G.N.K. Ganesh1★, K.P. Arun2, S.D. Rajendran3★ Corresponding author
- 1Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund, Tamil Nadu, India.
- 2Department of Pharmacy Practice, JSS College of Pharmacy, Ootacamund, Tamil Nadu, India.
- 3Scitus Pharma Services Pvt. Ltd., Kattupakkam, Chennai, Tamil Nadu, India.
CORRESPONDENCE
G.N.K. Ganesh
Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund, Tamil Nadu 643001, India.
Received: 25-07-2023; Revised: 28-09-2023; Accepted: 29-09-2023.
Volume 14, Issue 3 · pp. 178–186 · PUBLISHED 2023 · DOI: 10.1177/0976500X231211401
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Warfarin is the most commonly prescribed anti-coagulant medication. Warfarin’s pharmacokinetics (PK) in its enantiomeric form have been reported to be highly variable. Five population pharmacokinetic model studies for warfarin were identified in this systematic review. This review summarized these studies and reported on various factors affecting warfarin PK. Most studies reported a one-compartment model with first-order absorption and elimination for both S-warfarin and R-warfarin. Warfarin disposition has been reported to be influenced by various factors, including gender, age, genetic variation, body surface area (BSA), concurrent drug, weight, and ethnicity. So, all of these factors must be considered when addressing this pharmacokinetic variability. These models should undergo an external evaluation to confirm their generalizability and to support model-informed dosing in clinical settings.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Mahaboob, S., Ganesh, G., Arun, K., & Rajendran, S. (2023). Various Factors Influencing the Enantiomers of Warfarin Pharmacokinetics: A Systematic Review of Population Pharmacokinetics. Journal of Pharmacology and Pharmacotherapeutics, 14(3), 178–186. https://doi.org/10.1177/0976500X231211401
